Gene · 7357
Papers2,116
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,116
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sphingolipid metabolism-related genes as diagnostic markers in pneumonia-induced sepsis: the AUG model. | Sci Rep | 2025 | 40394027 | PubTator, text mining | PubMed |
| Single-cell mass spectrometry imaging of lipids in HeLa cells via tapping-mode scanning probe electrospray ionization. | Commun Chem | 2025 | 40369247 | PubTator, text mining | PubMed |
| Drug Resistance: The Role of Sphingolipid Metabolism. | Int J Mol Sci | 2025 | 40332322 | PubTator, text mining | PubMed |
| Integrating Machine Learning and Bulk and Single-Cell RNA Sequencing to Decipher Diverse Cell Death Patterns for Predicting the Prognosis of Neoadjuvant Chemotherapy in Breast Cancer. | Int J Mol Sci | 2025 | 40332226 | PubTator, text mining | PubMed |
| ɑ1,3-mannosyltransferase promotes the malignant progression of bladder cancer through activating TNF signaling pathway. | Eur J Med Res | 2025 | 40312703 | PubTator, text mining | PubMed |
| Selective requirement of glycosphingolipid synthesis for natural killer and cytotoxic T cells. | Cell | 2025 | 40306279 | PubTator, text mining | PubMed |
| Bombyx mori nuclear polyhedrosis virus infection regulated by host glycosphingolipids. | Pestic Biochem Physiol | 2025 | 40262890 | PubTator, text mining | PubMed |
| Eliglustat and cardiac comorbidities in Gaucher disease: a pharmacogenomic approach to safety and efficacy. | Front Med (Lausanne) | 2025 | 40166071 | PubTator, text mining | PubMed |
| Targeting Glucosylceramide Synthase: Innovative Drug Repurposing Strategies for Lysosomal Diseases. | Int J Mol Sci | 2025 | 40076817 | PubTator, text mining | PubMed |
| Drug-drug interaction study with itraconazole supplemented with physiologically based pharmacokinetic modelling to characterize the effect of CYP3A inhibitors on venglustat pharmacokinetics. | Br J Clin Pharmacol | 2025 | 40066762 | PubTator, text mining | PubMed |
| Integrated Analysis to Reveal Heterogeneity of Tumor-Associated Neutrophils in Glioma. | Cancer Med | 2025 | 40052358 | PubTator, text mining | PubMed |
| Phospholipids and Sphingolipids in Osteoarthritis. | Biomolecules | 2025 | 40001553 | PubTator, text mining | PubMed |
| SLO co-opts host cell glycosphingolipids to access cholesterol-rich lipid rafts for enhanced pore formation and cytotoxicity. | mBio | 2025 | 39835825 | PubTator, text mining | PubMed |
| UGCG promotes chemoresistance and breast cancer progression via NF-κB and Wnt/β-catenin pathway activation. | Transl Oncol | 2025 | 39674092 | PubTator, text mining | PubMed |
| Inhibiting UGCG prevents PRV infection by decreasing lysosome-associated autophage. | Int J Biol Macromol | 2025 | 39631580 | PubTator, text mining | PubMed |
| Lipid metabolism subtypes reflects the prognosis and immune profiles of bladder cancer patients by NMF clustering and building related signature. | Discov Oncol | 2024 | 39692922 | PubTator, text mining | PubMed |
| Glucosylceramide synthase inhibitor ameliorates chronic inflammatory pain. | J Pharmacol Sci | 2024 | 39608848 | PubTator, text mining | PubMed |
| UDP-glucose ceramide glucosyltransferase specifically upregulated in plasmacytoid dendritic cells regulates type I interferon production upon CpG stimulation. | Biochem Biophys Res Commun | 2024 | 39307111 | PubTator, text mining | PubMed |
| Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trial. | Nat Commun | 2024 | 39138212 | PubTator, text mining | PubMed |
| Ceramide metabolism alterations contribute to Tumor Necrosis Factor-induced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patients. | Front Immunol | 2024 | 39136013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7357/papers?page=4